Drug Shortage Report for BOOSTRIX-POLIO
Report ID | 196056 |
Drug Identification Number | 02312557 |
Brand name | BOOSTRIX-POLIO |
Common or Proper name | Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | INACTIVATED POLIOVIRUS TYPE III INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE I PERTACTIN ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTUSSIS TOXOID ADSORBED TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED |
Strength(s) | 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10's |
ATC code | J07CA |
ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-06-20 |
Estimated end date | 2023-10-18 |
Actual end date | 2023-10-02 |
Shortage status | Resolved |
Updated date | 2023-10-04 |
Company comments | Supply unavailable |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-10-04 | French | Compare |
v5 | 2023-10-04 | English | Compare |
v4 | 2023-06-21 | French | Compare |
v3 | 2023-06-21 | English | Compare |
v2 | 2023-06-21 | French | Compare |
v1 | 2023-06-21 | English | Compare |
Showing 1 to 6 of 6